‘Long Covid’ (post-covid syndrome): Mechanism of occurrence, diagnosis and rehabilitation
https://doi.org/10.33667/2078-5631-2021-41-20-26
Abstract
The article is devoted to the study of an urgent problem of modern humanity – the fight against a pandemic caused by a new coronavirus infection, namely: the study of the mechanism of development of ‘long Covid’ (post-covid syndrome), a new clinical and laboratory method of its diagnosis, issues of drug and non-drug rehabilitation of patients who have suffered COVID‑19. The paper describes the etiopathogenesis of post-covid syndrome (PS), the distinctive features of which are the defeat of the cardiovascular, respiratory, nervous, digestive, immune systems of the body, ENT organs and musculoskeletal system. For the diagnosis of post-covid syndrome, a monochrome nanoparticle analyzer (MAN) has been tested for the first time in the Russian Federation, which allows determining pathophysiological shifts in the homeostasis system. It was found that the MAN method has a sufficiently high diagnostic sensitivity (78%), and shifts in the homeostasis system in post-covid syndrome are statistically significant (p < 0.001). A fundamentally important point of this study is that an algorithm has been developed for noninvasive diagnosis of PS by saliva (oropharyngeal flushes), based on the detection of a high contribution to the scattering of laser radiation in the mid-frequency range of the spectrum on nanoparticles ranging in size from 119 to 121 nm. The article also pays special attention to medicinal and non-medicinal methods of treatment of patients with ‘long Covid’ experiencing the consequences of a new coronavirus infection. It has been established that the best effect is provided by complex treatment combining methods of the traditional European school (drug therapy with the use of cardiovascular drugs, nootropic agents, chondroprotectors, vitamins and mineral complexes, hormones, hepatoprotectors, biostimulants, sedatives and anti-inflammatory drugs and other drugs) and non-drug methods of restorative treatment practiced by Oriental medicine (acupuncture, hirudotherapy, massage, osteopathy, etc.).
About the Author
E. G. Choi
Centre of European and Oriental Medicine (‘Dr. Choi’ Co.)
Russian Federation
Russian Federation
Choi Yong Joon, DM Sci (habil.), physician of superior expert category, chief physician of the Centre
Moscow
References
1. Pokrovsky VI, Kiselev OI, Nazarov PG. SARS: severe acute respiratory syndrome. New virus, new disease. Tsitokiny i vospalenie. Cytokines and Infl ammation. 2003; 2 (2): 42–51 (In Russ.)
2. Bulanov A. Yu., Roitman E.V. Novaya koronavirusnaya infekciya, sistema gemostaza i problemy dozirovaniya geparinov: eto vazhno skazat’ sejchas. Tromboz, gemostaz i reologiya. 2020; 2: 11–18. (In Russ) DOI:10.2555/THR.2020.2.0913.
3. Vremennye metodicheskie rekomendacii “Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID‑19)”. 7 versiya. Available from: http://mpmo.ru/content/2020/06/Metodicheskie-recomendatsii-minzdra-va-RF-versiya-7.pdf. (In Russ)
4. Paules CI, Marston HD, Fauci AS. Coronavirus infections – more than just the common cold. JAMA. 2020; 323 (8): 707–8. https://doi.org/10.1001/jama.2020.0757
5. Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020. [Epub ahead of print] https://doi.org/10.1002/jmv.25709
6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl. J Med. 2020. [Epub ahead of print] https://doi.org/10.1056/NEJMoa2002032
7. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) – China, 2020. China CDC Weekly. 2020; 2 (8): 113–22.
8. Rosio H, Varpula M, Hagve TA, Karlsson S, Ruokonen E, Pettilä V, et al. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med. 2011; 37 (1): 77–85. https://doi.org/10.1007/s00134–010–2051-x
9. Klompas M, Branson R, Eichenwald EC, Greene LR, Howell MD, Lee G, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014; 35 (8): 915–36. https://doi.org/10.1086/677144
10. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006; 3 (9): e343. https://doi.org/10.1371/journal.pmed.0030343
11. WHO. Coronavirus disease (COVID‑19) pandemic. Geneva: WHO; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
12. World Health Organization. Infection prevention and control during health care when COVID-19 is suspected. Available from: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125.
13. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) – China, 2020. China CDC Weekly. 2020, 2 (8): 113–122. Available from: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4–41e9–9a9b-fea8db1a8f51.
14. Атлас по медицинской микробиологии, вирусологии и иммунологии. Учебное пособие для студентов медицинских вузов/ Под ред. А.А. Воробьева, А.С. Быкова. М.: Медицинское информационное агентство, 2003. 121 с.
15. Atlas po meditsinskoy mikrobiologii, virusologii i immunologii. Uchebnoye posobiye dlya studentov meditsinskikh vuzov. Ed by A.A. Vorob’yev, A. S. Bykov. Moscow: Meditsinskoye informatsionnoye agentstvo; 2003. 121 p. (In Russ.)
16. Woo P, Huang Y, Lau S, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses. 2010; 2 (8): 1804–1820. DOI:10.3390/v2081803.
17. Gaunt ER, Hardie A, Claas EC, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex realtime PCR method. J Clin Microbiol. 2010; 48 (8): 29407294. DOI:10.1128/JCM.00636–10.
18. Gaunt ER, Hardie A, Claas EC, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex realtime PCR method. J Clin Microbiol. 2010; 48 (8): 2940–2947. DOI:10.1128/JCM.00636–10.
19. Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev. 2007; 20 (4): 660–694. DOI:10.1128/CMR.00023–07.
20. Wolfel R, Corman MV, Guggemos W, et al. Virological assessment of hospitalized cases of coronavirus disease 2019. Nature. 2020. DOI:10.1038/s41586–020–2196-x.
21. Alserehi H., Wali G., Alshukairi A., Alraddadi B. Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome. BMC Infect Dis. 2016; 16: 105–108.
22. Bassetti M. The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm. https://doi.org/10.1111/eci.13209 URL: https://onlinelibrary.wiley.com/doi/abs/10.1111/eci.13209
23. Cao B., Wang Y., Wen D. et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. New England Jurnal Medicine.2020; DOI:10.1056/NEJMoa2001282.
Review
For citations:
Choi E.G. ‘Long Covid’ (post-covid syndrome): Mechanism of occurrence, diagnosis and rehabilitation. Medical alphabet. 2021;(41):20-26. (In Russ.) https://doi.org/10.33667/2078-5631-2021-41-20-26
Views:
725
Email this article 